Drug interactions
Cariprazine + Encorafenib
Severity: Moderate
Cariprazine and Encorafenib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib can both inhibit and induce CYP3A4, and cariprazine and its active metabolites are cleared mainly by CYP3A4. The net effect on cariprazine exposure is unpredictable, so there is a risk of either toxicity or loss of efficacy.
What this interaction means in plain words
Cariprazine and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Cariprazine belongs to Central Nervous System; Encorafenib belongs to Oncology.
Why it happens
Mixed CYP3A4 inhibition and induction by encorafenib altering cariprazine metabolism.
What to do
Monitor for adverse effects such as akathisia, sedation and parkinsonism, and for loss of psychiatric control. Adjust the cariprazine dose according to clinical response.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cariprazine and Encorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Cariprazine
Other interactions of Encorafenib
Frequently asked questions
Can I take Cariprazine with Encorafenib?
MediHelp rates the interaction as moderate. Cariprazine and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib can both inhibit and induce CYP3A4, and cariprazine and its active metabolites are cleared mainly by CYP3A4. The net effect on cariprazine exposure is unpredictable, so there is a risk of either toxicity or loss of efficacy.
How serious is the interaction between Cariprazine and Encorafenib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects such as akathisia, sedation and parkinsonism, and for loss of psychiatric control. Adjust the cariprazine dose according to clinical response.
What other medicines interact with Cariprazine?
MediHelp also lists interactions of Cariprazine with, for example, Alfentanil, Amisulpride, Amobarbital. The full list is on the Cariprazine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
